Matchpoint Therapeutics
Cambridge, United States· Est.
Matchpoint Therapeutics is developing covalent small molecule medicines to treat immunological and inflammatory disorders.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $70M
About
Matchpoint Therapeutics is developing covalent small molecule medicines to treat immunological and inflammatory disorders.
ImmunologySmall Molecules
Funding History
1Total raised:$70M
Series A$70M